Skip to main content

Advertisement

Log in

Plant flavonoids bioavailability in vivo and mechanisms of benefits on chronic kidney disease: a comprehensive review

  • Published:
Phytochemistry Reviews Aims and scope Submit manuscript

Abstract

Chronic kidney disease is a syndrome defined as the continuous change of renal structure, considered as one of the top 10 causes of death worldwide. In the past few decades, dietary flavonoids and their derivatives have been proved as potential drugs to control chronic kidney disease. There also seems to be a relationship between the intake of dietary flavonoids and nephropathy incidence. This study reviews the metabolism and bioavailability of plant flavonoids with different structures and their multifunctional role in inhibiting chronic kidney disease. The alleviating effect of plant flavonoids in chronic kidney disease is attributed to several mechanisms, including reduction of oxidative stress, immune modulation anti-inflammation, renal fibrosis inhibition, anti-apoptosis, and regulating gut flora. It also discussed how plant flavonoids regulate the intestinal flora of chronic kidney disease patients and further improve renal health through the gut-kidney axis. In addition, the products and development prospect of plant flavonoids are also introduced.

Graphical abstract

The main sources of flavonoids and their related mechanisms in the treatment of chronic kidney disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AT1:

Angiotensin type 1 receptor

C3G:

Cyanidin-3-glucoside

cAMP:

Cyclic adenosine monophosphate

CAT:

Catalase

CKD:

Chronic kidney disease

CRP:

C-reactive protein

COMT:

Catechol-O-methyltransferase

DKD:

Diabetic nephropathy

EMT:

Epithelial mesenchymal transition

ESRD:

End-stage renal disease

ECM:

Extracellular matrix

EGCG:

(-)-Epigallocatechin-3-gallate

GATA-3:

GATA binding protein 3

GN:

Glomerulonephritis

GSH:

Glutathione peroxidase

GSH-Px:

Glutathione peroxidase

IgA anti-GBM:

IgA anti-Glomerular basement membrane

IL-1:

Interleukin-1

IL-6:

Interleukin-6

IL-1β:

Interleukin-1β

indS:

Indoxyl sulfate

LPH:

Lactase phloridin hydrolase

MDA:

Malondialdehyde

MAPK:

Mitogen activated protein kinase

NF-κB:

Nuclear factor kappa-B

NOS:

Nitric oxide synthase

Nrf2:

Nuclear factor erythroid 2-related factor 2

PPAR-γ:

Peroxisome proliferator-activated receptor-γ

RNS:

Reactive nitrogen species

pCS:

P-Cresyl sulfate

ROS:

Reactive oxygen species

SCFA:

Short chain fatty acids

STAT3:

Signal transducer and activator of transcription 3

STAT-6:

Signal transducer and activator of transcription 6

SOD:

Superoxide dismutase

TGF-β1:

Transforming growth factor-β1

TMAO:

Trimethylamine-N-oxide

TNF-α:

Tumor necrosis factor-α

UGT:

UDP glucuronosyltransferase

References

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grant number 32072149, 32102006); Key Research and Development Program in Zhejiang province (Grant Number 2019C02070, 2021C02019); and Alexander von Humboldt foundation, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ping Shao.

Ethics declarations

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, Y., Fang, J., Zhang, Z. et al. Plant flavonoids bioavailability in vivo and mechanisms of benefits on chronic kidney disease: a comprehensive review. Phytochem Rev 22, 1541–1565 (2023). https://doi.org/10.1007/s11101-022-09837-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11101-022-09837-w

Keywords

Navigation